Maxim Group Starts BioLineRx (BLRX) at Buy; Sees a Double
Tweet Send to a Friend
Maxim Group initiates coverage on BioLineRx (NASDAQ: BLRX) with a Buy rating and a price target of $4.00.Analyst Jason Kolbert ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
